Krystal Biotech Q2 Earnings Call Highlights Krystal Biotech (
NASDAQ:KRYS ) reported second-quarter 2026 net revenue of $119.2 million from global sales of VYJUVEK, up 24% from $96 million in the prior-year period, as the company expanded treatment access for patients with dystrophic epidermolysis bullosa, or DEB, in the United States and overs
3 Biotech Firms With Major Potential Catalysts in the Coming Months The pharmaceutical industry is known for big risks and big rewards among investors; those willing to take on the risk may want to watch these firms.
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.
Why This Tech Fund Made a $5.8 Million Bet on an AI Chip Stock Up Nearly 200% Post-IPO Ambiq Micro designs ultra-low-power chips for wearables, IoT, and edge AI, targeting energy efficiency in connected devices.
This AI Semiconductor Stock Beat the S&P 500 by 9 Points. A Fund Just Exited Completely Ambarella delivers advanced semiconductor solutions for video, AI, and computer vision across automotive, security, and robotics markets.
Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position This clinical-stage biotech develops oral therapeutics for chronic diseases, targeting large global markets with unmet medical needs.
Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition technology.
Is Paymentus Stock a Buy After Palisades Investment Partners Increased Its Stake By $6 Million? Paymentus delivers cloud-based bill payment technology to major enterprises across regulated and service-intensive industries.
Is Amprius Technologies Stock a Buy After Palisades Investment Partners Initiated a Position Worth $4.8 Million? Amprius Technologies manufactures silicon nanowire lithium-ion batteries for aerospace, defense, and electric mobility markets.
Palisades Investment Partners Initiated a Position in SkyWater Technology Stock. What Does This Mean for Investors? SkyWater Technology delivers custom semiconductor solutions for sectors including aerospace, automotive, and industrial IoT.
What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment Viking Therapeutics develops clinical-stage therapies for metabolic and endocrine disorders, aiming to address unmet medical needs.
This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop This biopharma firm develops therapies for B-cell malignancies and autoimmune diseases, with a focus on oncology and immunology.
